Blue Jet Healthcare Q1 Results Review - Logistical Delays Hit Revenue Recognition: ICICI Securities
The company is guiding to grow revenue sharply with good new product pipeline, and expects to hold margin steady over the next two years, adds the brokerage.
Blue Jet Healthcare Ltd - 544009 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of the SEBI ( Listing Obligations and Disclosure Requirements) Regulation, 2015 we wish to inform you that the Company will be meeting several Investors/analysts in a physical group meeting at Emkay Confluence to be held on 13th August, 2024 at the St. Regis. Mumbai, Lower Parel Mumbai. Blue Jet Healthcare Ltd - 544009 - Submission Of Audio Recording Of Earnings Conference Call Pursuant To Regulation 30 Of The SEBI (LODR) Regulations
Submissions of Audio Recordings Q1FY25 Quarterly Result Announced for Blue Jet Healthcare Ltd
Pharmaceuticals company Blue Jet Healthcare announced Q1FY25 results: Revenue from operations for Q1FY25 stood at Rs 1,629 million which de-grew 9.3% on YoY basis compared to Rs 1,795 mnin Q1FY24. Gross Margin improved 2% in Q1FY25 (55% in Q1FY25 vs 53% in Q4FY24). This was due to change in Product Mix during June 24. EBITDA for the quarter came at Rs 443 million, which was down 24.9% YoY compared to Rs 590 million in Q1FY24. EBITDA margin for the quarter came at 27.2% as compared to 32.8% in Q1FY24, down 566 bps YoY. PAT for the quarter was at Rs 378 million, which de-grew 14.4% YoY compared to Rs 441 million in Q1FY24. There was an improvement of 2% as compared to Q4 FY24 due to Gross contribution improvement and rationalization of certain expenses. PAT margin for the quarter came at 23.2% as compared to 24.6% in Q1FY24, down 138 bps YoY. Total Treasury Investment and Cash & Cash Equivalent ason June 24 stands at Rs 3,781 million. Company successfully commissioned Plant 6 at Ambernath for manufacturing of Pharma intermediate with a Capacity of 120 KL and Investment of Rs 900 million. Result PDF Blue Jet Healthcare Ltd - 544009 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI LODR Regulations, 2015 Please find enclosed newspaper advertisements made on 7th August, 2024 containing extracts of Un-Audited Standalone Financial Results for the first quarter ended 30th June, 2024. Blue Jet Healthcare Ltd - 544009 - Announcement under Regulation 30 (LODR)-Investor Presentation
Analyst/ Investor Presentation on the Unaudited Standalone Financial Results for the quarter ended 30th June, 2024 Blue Jet Healthcare Ltd - 544009 - Results- Financial Results For Quarter Ended June 30, 2024
Unaudited Financial Statement for the Quarter ended June 30, 2024 along with LRR as received from Statutory Auditors Blue Jet Healthcare Ltd - 544009 - The Company Has Fixed 18Th September, 2024 As Record Date For The Purpose Of Dividend
The company has fixed 18th September, 2024 as Record date for the purpose of dividend of Re. 1 (50%) per equity share of Face value Rs. 2 each for FY 23-24 as recommended by Board of Directors at its meeting held on 25th May, 2024 subject to shareholders approval. Blue Jet Healthcare Ltd - 544009 - Board Meeting Outcome for Outcome Of Board Meeting Q1
Outcome of Board Meeting Q1 Blue Jet Healthcare Ltd - 544009 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In terms of regulation 30 read with schedule III, PART A SEBI LODR , Regulations 2015. We would like you inform you that a conference call for analysts and investors has been scheduled on Wednesday, August 7, 2024 at 4:00 PM (IST) to discuss the Unaudited Standalone Financial Results of the Company for the first quarter ended 30th June 2024.